Category: Pharma

July 15, 2022

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics. There’s […]

July 14, 2022

In a statement, the health technology assessment (HTA) organisation said that the two drugs were backed after an agreement with the two developers on pricing that will make them an option for around 3,450 NHS patients. Trodelvy (sacituzumab govitecan) can […]

July 12, 2022

The move comes as access to birth control becomes a pivotal issue following the landmark ruling by the Supreme Court last month to strip US women of their constitutional protection for the right to abortion, although the company says that […]

July 12, 2022

The deal centres on La Jolla’s lead product Giapreza (angiotensin II), used to increase blood pressure in adults with septic shock, and antibiotic Xerava (eravacycline) for complicated intra-abdominal infections (cIAIs), approved by the FDA in 2017 and 2018, respectively. La […]

July 7, 2022

When COVID-19 first emerged, scientists cautioned that developing an effective and safe vaccine could take longer than the commonly estimated figure of a year. The reason for the caution was that the previous quickest turnaround of a vaccine was for […]

June 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. However, this picture of recovery hides a […]

June 27, 2022

Relay has raised more than $1 billion on the promise that its protein motion technology can help it discover and develop better drugs in less time. Its efforts remain in early stages and, so far, don’t prove its approach can […]

June 22, 2022

In a global economy, across a number of industries, low-margin products are often manufactured in countries where labour is cheap. The pharmaceutical industry is no different, with India and China becoming two of the leading manufacturers and exporters of generic […]

April 21, 2022

Bora Pharmaceuticals, a fast-growing contract development and manufacturing organization (CDMO), is investing more than $10 million over the next 2 years to expand its oral solid dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario. The company’s CEO, Bobby […]

April 12, 2022

To further encourage pharmaceutical companies to invest in the reliable production of higher quality products, FDA is reviving efforts to establish a Quality Management Maturity (QMM) program. An updated version of this approach is spelled out in a new White […]

March 28, 2022

With new strains of the coronavirus showing their elusiveness and pushing more antibody treatments toward irrelevance, is there danger of an over-reliance on COVID-19 oral antivirals, especially Pfizer’s Paxlovid? Friday, the U.S. paused the distribution of GlaxoSmithKline and Vir Biotechnology’s […]

March 3, 2022

If you think Bayer’s recent $180 million sale of a drug manufacturing facility in Germany means the company is scaling back on production in its home country, think again. Bayer plans to invest 1.4 billion euros ($1.55 billion) in its […]

February 25, 2022

A study by researchers at Northwest A&F University in China has found that the anti-tumor drug, camptothecin (CPT) promotes weight loss in mice at low doses by activating a natural hunger-suppressing pathway. The study, headed by Jiang Wei Wu, PhD, […]

February 15, 2022

For Ford, the focus was on his company’s new range of consumer ‘biowearable’ health devices, but his appearance was also another reminder of the increasing importance of ‘digital’ in all its forms across the life sciences sector. Alongside buzzworthy metaverse, […]

February 1, 2022

Bacteria that can defeat current antibiotic drugs are sometimes called “the next pandemic.” Already, infections from them are believed to cause or contribute to more deaths worldwide than HIV/AIDS and malaria combined. Yet the pharmaceutical industry has been slow to […]

December 23, 2021

“There is some brilliant work that takes place by some incredibly intelligent agencies and individuals, but I know how formulaic we’ve become as an industry where next year’s tactics are probably very similar to this year’s tactics,” he says. “What […]

November 29, 2021

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies. It will take place […]

November 18, 2021

The initial deal between Gilead and Arcus gave the larger drugmaker rights to an experimental drug called zimberelimab, which attacks cancers using the same mechanism as Keytruda, along with an option to license the four projects covered by Thursday’s announcement. […]

November 12, 2021

Faced with the failure of a key clinical trial, a California-based biotech is pressing ahead with plans to test its experimental Alzheimer’s drug in another study, convinced that signs of benefit observed in some patients are proof its treatment works. […]

November 10, 2021

The latest agreement – worth around $1 billion – means that the US has now called dibs on 3.1 million doses of molnupiravir, which was approved in the UK as a treatment for people with mild to moderate COVID-19 who […]